RecruitingNot Applicable

Phase II Trial of Immunonutrition in Hepatectomy

India100 participantsStarted 2025-10-03

Plain-language summary

A randomised open labelled study to evalaute the impact of immunonutrition in Patients Undergoing Hepatectomies for Liver Tumors

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Patients with liver tumors planned for major hepatectomies (defined as resection of \>/= 3 liver segments)
✓. Age above 18 years
✓. ASA class I-III

✕. Preoperative severe renal failure (estimated glomerular filtration rate \< 30 ml/min)
✕. History of hypersensitivity to arginine, omega-3 fatty acids, or nucleotide 3. Inability to take oral nutrition

Preoperative immunonutrition improves prognostic nutritional index (PNI)

Timeframe: 90 days

NCT IDNCT07395635

SponsorTata Memorial Centre

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-10-31

Dr. Shraddha Patkar, MD MCh